Thromb Haemost 2009; 101(01): 215-216
DOI: 10.1160/TH08-05-0325
Letters to the Editor
Schattauer GmbH

Plasma Gas6 levels and coronary artery disease

Delphine Borgel
1   AP-HP, Hôpital Européen Georges Pompidou, Laboratoire d’Hématologie A, France, Paris, France
3   Univ. Paris-Sud, Faculty of Pharmacy, Châtenay-Malabry, France
,
Eric Durand
2   AP-HP, Hôpital Européen Georges Pompidou, Pôle Cardiovasculaire, France, Paris, France
,
Sylvain Clauser
1   AP-HP, Hôpital Européen Georges Pompidou, Laboratoire d’Hématologie A, France, Paris, France
4   Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 765, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France
,
Christilla Bachelot-Loza
4   Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 765, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France
,
Séverine Peyrard
5   AP-HP, Hôpital Européen Georges Pompidou, Paris, France
6   URC, Paris, France
,
Véronique Remones
1   AP-HP, Hôpital Européen Georges Pompidou, Laboratoire d’Hématologie A, France, Paris, France
,
Martine Aiach
1   AP-HP, Hôpital Européen Georges Pompidou, Laboratoire d’Hématologie A, France, Paris, France
,
Antoine Lafont
2   AP-HP, Hôpital Européen Georges Pompidou, Pôle Cardiovasculaire, France, Paris, France
› Author Affiliations
Financial support: This study was supported a by the Leducq Transatlantic Network of Excellence on Atherothrombosis Research and by a grant from Assistance Publique Hôpitaux de Paris (AP-HP).
Further Information

Publication History

Received: 26 May 2008

Accepted after major revision: 02 October 2008

Publication Date:
23 November 2017 (online)

 

 
  • References

  • 1 Tjwa M, Bellido-Martin L, Lin Y. et al. GAS6 promotes inflammation by enhancing interactions between endothelial cells, platelets and leukocytes. Blood 2008; 111: 4096-4105.
  • 2 Angelillo-Scherrer A, de Frutos P, Aparicio C. et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001; 07: 215-221.
  • 3 Angelillo-Scherrer A, Burnier L, Flores N. et al. Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest 2005; 115: 237-246.
  • 4 Durand E, Scoazec A, Lafont A. et al. In vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion. Circulation 2004; 109: 2503-2506.
  • 5 Melaragno MG, Fridell YW, Berk BC. The Gas6/Axl system: a novel regulator of vascular cell function. Trends Cardiovasc Med 1999; 09: 250-253.
  • 6 Nakano T, Higashino K, Kikuchi N. et al. Vascular smooth muscle cell-derived, Gla-containing growth-potentiating factor for Ca(2+)-mobilizing growth factors. J Biol Chem 1995; 270: 5702-5705.
  • 7 D’Arcangelo D, Gaetano C, Capogrossi MC. Acidification prevents endothelial cell apoptosis by Axl activation. Circ Res 2002; 91: e4-12.
  • 8 Clauser S, Peyrard S, Gaussem P. et al. Development of a novel immunoassay for the assessment of plasma Gas6 concentrations and their variation with hormonal status. Clin Chem 2007; 53: 1808-1813.
  • 9 Borgel D, Clauser S, Bornstain C. et al. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit Care Med 2006; 34: 219-222.
  • 10 Muñoz X, Obach V, Hurtado B. et al. Association of specific haplotypes of GAS6 gene with stroke. Thromb Haemost. 2007; 98: 406-412.
  • 11 Balogh I, Hafizi S, Stenhoff J. et al. Analysis of Gas6 in human platelets and plasma. Arterioscler Thromb Vasc Biol 2005; 25: 1280-1286.
  • 12 Clauser S, Bachelot-Lozat C, Fontana P. et al. Physiological plasma Gas6 levels do not influence platelet aggregation. Arterioscler Thromb Vasc Biol 2006; 26: e22.